期刊文献+

流感裂解疫苗纯化及裂解工艺的优化 被引量:5

Optimization of Procedure for Purification and Lysis of Influenza Virus Vaccine
下载PDF
导出
摘要 目的优化大规模生产的流感病毒裂解疫苗的纯化及裂解工艺。方法比较凝胶层析和蔗糖密度梯度超速离心的纯化效果,以及TritonX-100和去氧胆酸钠两种裂解剂在不同条件下的裂解效果。结果层析法纯度稍高于蔗糖密度梯度超速离心法,而蔗糖密度区带超速离心法的收率优于层析法。TritonX-100的裂解效果优于去氧胆酸钠,裂解剂浓度为0.5%或0.8%,裂解3或4h,裂解率达90%以上。疫苗在4℃保存1年后,所有检测项目均合格,4℃保存18个月和37℃保存28d后,HA含量仍保持在30μg/ml以上。结论已建立了切实可行的流感病毒裂解疫苗规模生产的纯化及裂解工艺。 Objective To optimize the procedure for purification and lysis of influenza virus vaccine.Methods Compare the purification efficacies by gel filtration chromatography and by sucrose density gradient centrifutgation, as well as the lysis efficacies with Triton X-100 and with sodium deoxycholate under various conditions.Results The purity of split influenza vaccine after purification by gel filtration chromatography was slightly higher than that by sucrose density gradient ultracentrifugation, while the recovery of vaccine by the latter was higher than that by the formet.Triton X-100 showed good lysis efficacy as compared with sodium deoxycholate. After lysis with Triton X-100 at a final concentration of 0.5% or 0.8% for 3 or 4 h, more than 90% of influenza vaccine was lyzed. After storage at 4℃ for 12 months, all the quality indexes of the purified vaccine met the relevant requirements. However, after storage at 4℃ for 18 months or at 37℃ for 28 d , the HA content of vaccine was still more than 30 μg/ml. Conclusion A practical and feasible procedure for purification and lysis of influenza vaccine was developed.
出处 《中国生物制品学杂志》 CAS CSCD 2008年第1期36-39,共4页 Chinese Journal of Biologicals
关键词 流感裂解疫苗 纯化 裂解 Split influenza virus vaccine Purification Lysis
  • 相关文献

参考文献4

  • 1Wiliams MS, Mayner RE, Daniel NJ, et al. New developments in the measurement of haemagglutinin content of influenza virus vaccines by singleradial-immunodiffusion.J Biol Stand, 1980,8:289-296. 被引量:1
  • 2Gerdil C.The annual production cycle for influenza vaccine. Vaccine,2003,21 (16):1776-1779. 被引量:1
  • 3Warburton MF. Desoxycholste-split influenza vaccine. Bull World Health Organ, 1969,41 (3) :639-641. 被引量:1
  • 4Gross PA, Ennis FA, Gaerlan PF,et al. Comparison of new triton X-100 and tween-ether-treated split-treated vaccines in children. J Clin Microbiol, 1981,14(5) :534-538. 被引量:1

同被引文献23

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部